TURGEON JOSEPH W. (CEO & President) sold 2.0% of their position (7.73K shares) of SPECTRUM PHARMACEUTICALS INC on the open market
Open‑market sale worth $31.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/20/2021ACC: 0001209191-21-004578
DirectorOfficer· CEO & President
Since Jan 2019
-7.73K
Net shares
Net seller
$31.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
7.73K disposed
Non-Derivative Transactions2
Common Stock, $0.001 par value
Direct
Shares
−3.84K
Price / share
$3.81
Trade value
$14.64K
% of position
1.0%
1/19/2021
377.76K→373.92K
Common Stock, $0.001 par value
Direct
Shares
−3.89K
Price / share
$4.31
Trade value
$16.76K
% of position
1.0%
1/20/2021
373.92K→370.03K
Total
Net shares
−7.73K
Net value
-$31.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 1/19/2021 | S · Sale | −3.84K | $3.81 | $14.64K | 1.0% | 377.76K | 373.92K |
| Common Stock, $0.001 par value Direct | 1/20/2021 | S · Sale | −3.89K | $4.31 | $16.76K | 1.0% | 373.92K | 370.03K |
| Total | −7.73K | -$31.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.001 par value
IndirectShares owned1.54K
Total
1.54K indirect1.54K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 1.54K | Indirect |
| Total | 1.54K | 1.54K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported